ALISON E. BAIRD
Medical Practice in Bethesda, MD
License number
DC MD036346
Issued Date
Dec 9, 2006
Expiration Date
Dec 31, 2008
Category
MEDICINE
Type
MEDICINE AND SURGERY
Address
Address
Ninds / Nih Stroke Neuroscience Unit UNIT NEUROSCIENCE, Bethesda, MD 20892
Personal information
See more information about ALISON E. BAIRD at radaris.comName
Address
Phone
7500 Woodmont Ave, Bethesda, MD 20814
Professional information
Alison E Baird, Bethesda MD
Specialties:
Neurology, Internal Medicine
Address:
VALID FOR US CIVIL SERVICE EMPLOYEE ON
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
Suny Downstate Med Ctr Nrlgy
450 Clarkson Ave SUITE 1274, Brooklyn 11203
(718) 221-5188 (Phone)
10 Ctr Dr, Bethesda 20892
(301) 496-0207 (Phone)
Suny Downstate Med Ctr Nrlgy
450 Clarkson Ave SUITE 1274, Brooklyn 11203
(718) 221-5188 (Phone)
Languages:
English
Education:
Medical School
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 2009
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 2009
Differential Expression Of Molecules Associated With Acute Stroke
US Patent:
2006004, Mar 2, 2006
Filed:
Jun 17, 2005
Appl. No.:
11/155835
Inventors:
Alison Baird - Bethesda MD, US
David Moore - Rockville MD, US
Ehud Goldin - Rockville MD, US
David Moore - Rockville MD, US
Ehud Goldin - Rockville MD, US
International Classification:
C12Q 1/68, G01N 33/00
US Classification:
435006000, 436086000
Abstract:
Methods are provided for evaluating a stroke, for example for determining whether a subject has had an ischemic stroke, determining the severity or likely neurological recovery of a subject who has had an ischemic stroke, and determining a treatment regimen for a subject who has had an ischemic stroke, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes screening for expression in ischemic stroke related genes (or proteins), such as white blood cell activation and differentiation genes (or proteins), genes (or proteins) related to hypoxia, genes (or proteins) involved in vascular repair, and genes (or proteins) related to a specific peripheral blood mononuclear cell (PBMC) response to the altered cerebral microenvironment. Also provided are methods of identifying one or more agents that alter the activity (such as the expression) of an ischemic stroke-related molecule.
Differential Expression Of Molecules Associated With Acute Stroke
US Patent:
2010026, Oct 21, 2010
Filed:
Jul 1, 2010
Appl. No.:
12/829229
Inventors:
ALISON E. BAIRD - BETHESDA MD, US
DAVID F. MOORE - ROCKVILLE MD, US
EHUD GOLDIN - ROCKVILLE MD, US
DAVID F. MOORE - ROCKVILLE MD, US
EHUD GOLDIN - ROCKVILLE MD, US
International Classification:
C40B 30/04, C12Q 1/68, C40B 40/08
US Classification:
506 9, 435 6, 506 17
Abstract:
Methods are provided for evaluating a stroke, for example for determining whether a subject has had an ischemic stroke, determining the severity or likely neurological recovery of a subject who has had an ischemic stroke, and determining a treatment regimen for a subject who has had an ischemic stroke, as are arrays and kits that can be used to practice the methods. In particular examples, the method includes screening for expression in ischemic stroke related genes (or proteins), such as white blood cell activation and differentiation genes (or proteins), genes (or proteins) related to hypoxia, genes (or proteins) involved in vascular repair, and genes (or proteins) related to a specific peripheral blood mononuclear cell (PBMC) response to the altered cerebral microenvironment. Also provided are methods of identifying one or more agents that alter the activity (such as the expression) of an ischemic stroke-related molecule.